Ｃｈｏｒｄｉａ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ．
Ｃｈｏｒｄｉａ Ｔｈｅｒａｐｅｕｔｉｃｓ株式会社
Valuation
Fundamental ratios for the latest reported period.
Ticker: 190A
FY2024 · 2025-08-31
| Gross margin | — |
| Operating margin | — |
| Net margin | — |
| Return on equity | — |
| Return on assets | -66.6% |
| Revenue growth (YoY) | — |
| EPS (basic) | ¥-26.03 |
| EPS growth (YoY) | — |
| Current ratio | 10.92x |
| Equity ratio | 90.8% |
| Book value / share | ¥35.29 |
| Free cash flow | -1,842 M |